 | • レポートコード：QYR9N7589 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、分子診断とNATのグローバル市場について調査・分析したレポートで、種類別（増幅テクノロジー、増幅遺伝子検出技術、DNAとオリゴヌクレオチドマイクロアレイ、遺伝子シーケンス）、用途別（病院と診療所、研究機関、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・分子診断とNATの世界市場規模 ・主要企業別市場シェア ・分子診断とNATの世界市場規模：種類別（増幅テクノロジー、増幅遺伝子検出技術、DNAとオリゴヌクレオチドマイクロアレイ、遺伝子シーケンス） ・分子診断とNATの世界市場規模：用途別（病院と診療所、研究機関、診断センター） ・分子診断とNATのアメリカ市場規模（種類別、用途別） ・分子診断とNATのヨーロッパ市場規模（種類別、用途別） ・分子診断とNATの中国市場規模（種類別、用途別） ・分子診断とNATの日本市場規模（種類別、用途別） ・分子診断とNATの東南アジア市場規模（種類別、用途別） ・分子診断とNATのインド市場規模（種類別、用途別） ・分子診断とNATの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・分子診断とNATの世界市場予測（2019年-2025年） ・分子診断とNATの地域別市場予測（2019年-2025年） ... |
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
In 2018, the global Molecular Diagnostics and NAT market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Molecular Diagnostics and NAT status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics and NAT development in United States, Europe and China.
The key players covered in this study
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Market segment by Type, the product can be split into
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Market segment by Application, split into
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Molecular Diagnostics and NAT status, future forecast, growth opportunity, key market and key players.
To present the Molecular Diagnostics and NAT development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Molecular Diagnostics and NAT are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (2014-2025)
1.4.2 Amplification Technologies
1.4.3 Amplified Gene Detection Technologies
1.4.4 DNA And Oligonucleotide Microarrays
1.4.5 Gene Sequencing
1.5 Market by Application
1.5.1 Global Molecular Diagnostics and NAT Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Research Institutes
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Molecular Diagnostics and NAT Market Size
2.2 Molecular Diagnostics and NAT Growth Trends by Regions
2.2.1 Molecular Diagnostics and NAT Market Size by Regions (2014-2025)
2.2.2 Molecular Diagnostics and NAT Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Molecular Diagnostics and NAT Market Size by Manufacturers
3.1.1 Global Molecular Diagnostics and NAT Revenue by Manufacturers (2014-2019)
3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
3.2 Molecular Diagnostics and NAT Key Players Head office and Area Served
3.3 Key Players Molecular Diagnostics and NAT Product/Solution/Service
3.4 Date of Enter into Molecular Diagnostics and NAT Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Molecular Diagnostics and NAT Market Size by Type (2014-2019)
4.2 Global Molecular Diagnostics and NAT Market Size by Application (2014-2019)
5 United States
5.1 United States Molecular Diagnostics and NAT Market Size (2014-2019)
5.2 Molecular Diagnostics and NAT Key Players in United States
5.3 United States Molecular Diagnostics and NAT Market Size by Type
5.4 United States Molecular Diagnostics and NAT Market Size by Application
6 Europe
6.1 Europe Molecular Diagnostics and NAT Market Size (2014-2019)
6.2 Molecular Diagnostics and NAT Key Players in Europe
6.3 Europe Molecular Diagnostics and NAT Market Size by Type
6.4 Europe Molecular Diagnostics and NAT Market Size by Application
7 China
7.1 China Molecular Diagnostics and NAT Market Size (2014-2019)
7.2 Molecular Diagnostics and NAT Key Players in China
7.3 China Molecular Diagnostics and NAT Market Size by Type
7.4 China Molecular Diagnostics and NAT Market Size by Application
8 Japan
8.1 Japan Molecular Diagnostics and NAT Market Size (2014-2019)
8.2 Molecular Diagnostics and NAT Key Players in Japan
8.3 Japan Molecular Diagnostics and NAT Market Size by Type
8.4 Japan Molecular Diagnostics and NAT Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Molecular Diagnostics and NAT Market Size (2014-2019)
9.2 Molecular Diagnostics and NAT Key Players in Southeast Asia
9.3 Southeast Asia Molecular Diagnostics and NAT Market Size by Type
9.4 Southeast Asia Molecular Diagnostics and NAT Market Size by Application
10 India
10.1 India Molecular Diagnostics and NAT Market Size (2014-2019)
10.2 Molecular Diagnostics and NAT Key Players in India
10.3 India Molecular Diagnostics and NAT Market Size by Type
10.4 India Molecular Diagnostics and NAT Market Size by Application
11 Central & South America
11.1 Central & South America Molecular Diagnostics and NAT Market Size (2014-2019)
11.2 Molecular Diagnostics and NAT Key Players in Central & South America
11.3 Central & South America Molecular Diagnostics and NAT Market Size by Type
11.4 Central & South America Molecular Diagnostics and NAT Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Diagnostics and NAT Introduction
12.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Diagnostics and NAT Introduction
12.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 BD
12.3.1 BD Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Diagnostics and NAT Introduction
12.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.3.5 BD Recent Development
12.4 Biomerieux
12.4.1 Biomerieux Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Diagnostics and NAT Introduction
12.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.4.5 Biomerieux Recent Development
12.5 Qiagen
12.5.1 Qiagen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Diagnostics and NAT Introduction
12.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.5.5 Qiagen Recent Development
12.6 Thermo Fisher Scientific
12.6.1 Thermo Fisher Scientific Company Details
12.6.2 Company Description and Business Overview
12.6.3 Molecular Diagnostics and NAT Introduction
12.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.6.5 Thermo Fisher Scientific Recent Development
12.7 Agilent
12.7.1 Agilent Company Details
12.7.2 Company Description and Business Overview
12.7.3 Molecular Diagnostics and NAT Introduction
12.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.7.5 Agilent Recent Development
12.8 GenMark
12.8.1 GenMark Company Details
12.8.2 Company Description and Business Overview
12.8.3 Molecular Diagnostics and NAT Introduction
12.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.8.5 GenMark Recent Development
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Company Details
12.9.2 Company Description and Business Overview
12.9.3 Molecular Diagnostics and NAT Introduction
12.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.9.5 Siemens Healthcare Recent Development
12.10 AutoGenomics
12.10.1 AutoGenomics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Molecular Diagnostics and NAT Introduction
12.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2014-2019)
12.10.5 AutoGenomics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Molecular Diagnostics and NAT Key Market Segments
Table Key Players Molecular Diagnostics and NAT Covered
Table Global Molecular Diagnostics and NAT Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size Market Share by Type 2014-2025
Figure Amplification Technologies Figures
Table Key Players of Amplification Technologies
Figure Amplified Gene Detection Technologies Figures
Table Key Players of Amplified Gene Detection Technologies
Figure DNA And Oligonucleotide Microarrays Figures
Table Key Players of DNA And Oligonucleotide Microarrays
Figure Gene Sequencing Figures
Table Key Players of Gene Sequencing
Table Global Molecular Diagnostics and NAT Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Research Institutes Case Studies
Figure Diagnostic Centers Case Studies
Figure Molecular Diagnostics and NAT Report Years Considered
Table Global Molecular Diagnostics and NAT Market Size 2014-2025 (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Molecular Diagnostics and NAT Market Size by Regions 2014-2025 (Million US$)
Table Global Molecular Diagnostics and NAT Market Size by Regions 2014-2019 (Million US$)
Table Global Molecular Diagnostics and NAT Market Share by Regions 2014-2019
Figure Global Molecular Diagnostics and NAT Market Share by Regions 2014-2019
Figure Global Molecular Diagnostics and NAT Market Share by Regions 2019
Table Market Top Trends
Table Global Molecular Diagnostics and NAT Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Molecular Diagnostics and NAT Market Share by Manufacturers (2014-2019)
Figure Global Molecular Diagnostics and NAT Market Share by Manufacturers in 2018
Table Global Molecular Diagnostics and NAT Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Molecular Diagnostics and NAT Product/Solution/Service
Table Date of Enter into Molecular Diagnostics and NAT Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table Global Molecular Diagnostics and NAT Market Size Share by Type (2014-2019)
Figure Global Molecular Diagnostics and NAT Market Size Market Share by Type (2014-2019)
Table Global Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table Global Molecular Diagnostics and NAT Market Size Share by Application (2014-2019)
Figure Global Molecular Diagnostics and NAT Market Size Market Share by Application (2014-2019)
Figure Global Molecular Diagnostics and NAT Revenue Market Share by Application in 2018
Figure United States Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table United States Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table United States Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table United States Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table United States Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table United States Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table United States Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Figure Europe Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table Europe Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table Europe Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table Europe Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table Europe Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table Europe Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table Europe Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Figure China Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table China Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table China Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table China Molecular Diagnostics and NAT Market Size by Type (2014-20189) (Million US$)
Table China Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table China Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table China Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Figure Japan Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table Japan Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table Japan Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table Japan Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table Japan Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table Japan Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table Japan Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Figure Southeast Asia Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Figure India Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table India Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table India Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table India Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table India Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table India Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table India Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Figure Central & South America Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Molecular Diagnostics and NAT Market Share (2018-2019)
Table Central & South America Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$)
Table Central & South America Molecular Diagnostics and NAT Market Share by Type (2014-2019)
Table Central & South America Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$)
Table Central & South America Molecular Diagnostics and NAT Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Molecular Diagnostics and NAT Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Roche Recent Development
Table Abbott Company Details
Table Abbott Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Abbott Recent Development
Table BD Company Details
Table BD Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure BD Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table BD Recent Development
Table Biomerieux Company Details
Table Biomerieux Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure Biomerieux Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Biomerieux Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Qiagen Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Agilent Company Details
Table Agilent Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure Agilent Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Agilent Recent Development
Table GenMark Company Details
Table GenMark Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure GenMark Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table GenMark Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table Siemens Healthcare Recent Development
Table AutoGenomics Company Details
Table AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$)
Figure AutoGenomics Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019)
Table AutoGenomics Recent Development
Table Global Molecular Diagnostics and NAT Market Size by Regions (Million US$) 2019-2025
Figure Global Molecular Diagnostics and NAT Market Size Share by Regions (2019-2025)
Figure Global Molecular Diagnostics and NAT Market Size Share by Regions in 2025
Figure United States Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Figure Europe Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Figure China Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Figure Japan Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Figure India Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD)
Table Global Molecular Diagnostics and NAT Market Size by Product (2019-2025) (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size by Product (2019-2025)
Figure Global Molecular Diagnostics and NAT Market Size by Product in 2025
Table Global Molecular Diagnostics and NAT Market Size by Application (2019-2025) (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size by Application (2019-2025)
Figure Global Molecular Diagnostics and NAT Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のPOC分子診断市場：市場規模・現状・予測 In 2018, the global POC Molecular Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global POC Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. …- 世界のNGSベースの診断市場：市場規模・現状・予測 Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is f…
- 世界の遺伝子発現検出キット市場2019 Gene Expression Detection Kits are used to study any gene or splicing variant of any organism. The global Gene Expression Detection Kit market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies the glo…
- 世界の分子品質管理市場：市場規模・現状・予測 Molecular quality control products for use in inherited disease testing, infectious disease detection, and pharmacogenetics.In 2018, the global Molecular Quality Controls market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025…
- 世界のRNA次世代シークエンシング市場：市場規模・現状・予測 RNA next-generation sequencing refer to the use of next-generation sequencing to reveal the presence and quantity of RNA in a biological sample at a given moment.In 2018, the global RNA Next-Generation Sequencing market size was xx million US$ and it is expected to reach xx million US$ by the end of…